Rick E. Winningham - 02 Apr 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
02 Apr 2024
Transactions value $
$0
Form type
4
Filing time
04 Apr 2024, 18:17:33 UTC
Previous filing
19 Mar 2024
Next filing
17 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $0 +300,000 +19.35% $0 1,850,573 02 Apr 2024 Direct F1
holding TBPH Ordinary Shares 3,900 02 Apr 2024 As Custodian
holding TBPH Ordinary Shares 92,567 02 Apr 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 2, 2024, the reporting person was granted 300,000 RSUs. 150,000 RSUs are subject to service-based vesting conditions and the remaining 150,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.